FREMONT, Calif., Sept. 9, 2015 — Optovue Inc. has announced AngioAnalytics, an angiography quantification system for the detection of eye disease based on optical coherence tomography. The device quantifies the density of blood flow in the retina, aiding ophthalmologists in detecting and managing eye diseases. Retina changes can be tracked objectively, potentially even before the patient notices significant vision degradation. The AngioVue imaging system forms detailed 3D images of the retina to visualize anatomic structures and abnormalities as a visual map of blood flow is created. The system is noninvasive and does not require dye injection.